Chinese shares opened lower on Thursday as state-backed purchases failed to stem a prolonged market decline.
The Shanghai Composite Index, the main gauge of Chinese stocks, opened 0.1% lower to 3,676.77. The Shenzhen Component Index declined 0.8% to 11,379.00.
State buying by Central Huijin Investment and other government-backed investors helped lift the CSI 300, but analysts cautioned that intervention alone was unlikely to sustain a broader recovery.
While the purchases could provide temporary support, a lasting rally would depend on stronger corporate earnings and domestic demand.
Separately, the U.S. banned imports from Chinese genomics companies BGI Genomics (SHE:300676), Shenzhen BGI Technology and MGI Tech (SHA:688114), citing alleged involvement in forced labor involving Uyghurs and other ethnic minorities in the Xinjiang Uyghur Autonomous Region.
Comments